Featured Products
Our Promise to You
Guaranteed product quality, expert customer support
ONLINE INQUIRY
PA-TU-8988S
Cat.No.: CSC-C0326
Species: Human
Source: pancreas adenocarcinoma
Morphology: adherent epitheloid cells growing in monolayers
Culture Properties: monolayer
- Specification
- Publications
- Q & A
- Customer Review
Immunology: cytokeratin +, cytokeratin-7 +, cytokeratin-8 +, cytokeratin-17 -, cytokeratin-18 +, cytokeratin-19 +, desmin -, endothel -, EpCAM +, GFAP -, neurofilament -,
Yes, there are several other cell culture media available that can be used as alternatives to Ham's F12 medium, such as Dulbecco's modified eagle medium (DMEM) or RPMI-1640. The choice of medium depends on the specific requirements of the cell line and the experiment being conducted.
Ask a Question
Average Rating: 5.0 | 1 Scientist has reviewed this product
Additional support
Creative Bioarray provides additional support, such as technical consultations or webinars, which can be beneficial for researchers aiming to maximize the value and utility of the tumor cell product, especially in relation to affordability.
21 Aug 2023
Ease of use
After sales services
Value for money
Write your own review
- You May Also Need
Description: Established in 1985 from the liver metastasis of a primary pancreatic adenocarcinoma from a 64-year-old woman; sister cell line of PA-TU-8988S
Description: Established in 1985 from the primary ductal pancreatic adenocarcinoma (grade II) from a 44-year-old woman; reported as inducing metastasis in nude mice and as secreting proteinases (e.g. urokinase, cathepsin B and D)
Description: Established from the malignant ascites of a 60-year-old Japanese man with pancreas carcinoma in 1985
Description: Established from the malignant ascites of a 66-year-old Japanese man with pancreas carcinoma in 1984
Description: Established from ascites obtained during exploratory laparatomy of a 43-year-old Japanese man with pancreas carcinoma (terminal, no therapy) in December 1993; cells were described as being dependent on autocrinely secreted IL-1alpha
Description: Originally described to be derived from the moderately differentiated adenocarcinoma of the head of the pancreas from a 74-year-old African-American man in 1996; patient was treated with pancreato-duodenectomy; cells were described as being tumorigenic in SCID mice; however, DNA fingerprinting and cytogenetic analysis showed cross-contamination with cell line HPAC which was established in 1985 from the pancreas adenocarcinoma of a 64-year-old Caucasian woman
